> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Biosimilars Head Christl Leaving FDA
- URL: https://www.fdaweb.com/biosimilars-head-christl-leaving-fda/
- Published: 2019-02-01T12:00:00.000Z
- Updated: 2026-09-15T00:59:50.000Z
- Author: David McFarland
- Tags: Biologics, Drugs, #legacy-id-D5143277

After 16 years at FDA, CDER Therapeutic Biologics and Biosimilars Staff director **Leah Christl** is leaving to pursue other opportunities, effective 2/22\. She joined FDA in 2003 as a regulatory project manager in the Over-the-Counter Drug Products Division. She later served as associate director for regulatory affairs for the Office of Drug Evaluation IV, and since 2010 she has overseen CDER’s biosimilars program.